Unspecified monoclonal antibody therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Unspecified monoclonal antibody therapy, covering 2013-10-31 to 2013-11-06. Get the full timeline:
Most recent: Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy [Phase 2]